Publicacións en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (32)

2024

  1. Systemic biomarker associated with poor outcome after futile reperfusion

    European Journal of Clinical Investigation, Vol. 54, Núm. 6

2023

  1. Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study

    Neurologia, Vol. 38, Núm. 6, pp. 412-418

2022

  1. Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology

    Neurologia, Vol. 37, Núm. 1, pp. 61-72

2021

  1. Article targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: Safety and optimal dose selection in a randomized clinical trial

    Antioxidants, Vol. 10, Núm. 8

  2. Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group

    Neurologia, Vol. 36, Núm. 6, pp. 462-471

  3. Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology

    Neurologia, Vol. 36, Núm. 4, pp. 305-323

2020

  1. Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

    Translational Stroke Research, Vol. 11, Núm. 4, pp. 653-663

  2. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

    The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584

  3. Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

    Neurological Research and Practice, Vol. 2, Núm. 1

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

2013

  1. Interleukin-10 facilitates the selection of patients for systemic thrombolysis

    BMC Neurology, Vol. 13

2012

  1. Usefulness of material recovered from distal embolic protection devices after carotid angioplasty for proteomic studies

    Journal of Vascular and Interventional Radiology, Vol. 23, Núm. 6, pp. 818-824

2011

  1. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels

    Clinical Science, Vol. 121, Núm. 1, pp. 11-17

  2. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke

    Stroke, Vol. 42, Núm. 10, pp. 2813-2818

  3. Impaired brachial flow-mediated dilation is a predictor of a new-onset vascular event after stroke

    Cerebrovascular Diseases, Vol. 32, Núm. 2, pp. 155-162

2010

  1. Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA

    Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 7, pp. 1567-1574

2009

  1. Age determines the effects of blood pressure lowering during the acute phase of ischemic stroke: The TICA study

    Hypertension, Vol. 54, Núm. 4, pp. 769-774

  2. Brachial arterial flow mediated dilation in acute ischemic stroke

    European Journal of Neurology, Vol. 16, Núm. 6, pp. 684-690

  3. High serum levels of leptin are associated with post-stroke depression

    Psychological Medicine, Vol. 39, Núm. 7, pp. 1201-1209

2008

  1. Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment

    Disease Markers, Vol. 25, Núm. 3, pp. 181-188